Rankings
▼
Calendar
LUNG Q2 2019 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena
LUNG
Pulmonx Corporation
$72M
Q2 2019 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$7M
Gross Profit
$5M
67.2% margin
Operating Income
-$5M
-65.9% margin
Net Income
-$6M
-75.6% margin
EPS (Diluted)
$-3.26
QoQ Revenue Growth
+12.1%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$62,500
← FY 2019
All Quarters
Q3 2019 →